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Clonal Spread of 
Streptococcus 
pyogenes emm44 
among Homeless 
Persons, Rennes, 
France
To the Editor: Streptococcus pyo-
genes, or group A streptococci (GAS), 
are human pathogens responsible for 
pharyngitis as well as skin and soft tis-
sue infections. Invasive GAS diseases, 
including bacteremia, cellulitis, and 
necrotizing fasciitis, are life-threaten-
ing, especially when associated with 
toxic shock syndrome. Several risk 
factors for GAS infections are known, 
such as diabetes, immunosuppression, 
drug use, and skin lesions (1,2).
In France in 2008, 12% of GAS 
strains were reported resistant to tetra-
cycline by the national reference center. 
Unexpected recognition of 8 tetracy-
cline-resistant GAS isolates in January 
and February 2009 at the 1,950-bed 
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Figure. Testing for xenotropic murine leukemia virus–related virus (XMRV) in patients with 
ﬁ  bromyalgia. Lanes 1 and 13, molecular weight marker ΦX174RF HaeIII; lanes 2–5, hBG 
for patients 1–4 (primers: hBG-FI-170/hBG-RI-273 (103 bp); lanes 6–12, positive control 
(pcDNA3.1-XMRV-Vp62) 1,000 copies (lanes 6 and 10) and 100 copies (lanes 7–9 and 
11–12); lane 6, primers gag 419F/1154R (735 bp); lane 7, primers gag MLV-GAG-I-F/MLV-
GAG-I-R (413 bp); lane 8, primers gag MLV-NP116/MLV-NP117 (380 bp); lane 9, primers 
gag XMRV-FI-441/XMRV-RI-566 (125 bp); lane 10, primers env 5922F/6273R (351 bp); 
lane 11, primers env 5922F/6173R (252 bp); lane 12, primers env 5942F/6159R (218 bp).LETTERS
University Hospital of Rennes in west-
ern France led to further investigation. 
We report results of characterization 
of tetracycline-resistant GAS isolates 
collected during 2009 from hospital-
ized and outclinic patients.
Isolates were identiﬁ  ed as GAS 
on the basis of β-hemolysis, Gram 
staining, negative catalase test result, 
positive pyrrolidonyl arylamidase test 
result, and agglutination with Lance-
ﬁ   eld group A antiserum. Antimicro-
bial drug susceptibility to penicillin 
G, amoxicillin, erythromycin, linco-
mycin, tetracycline, rifampin, strep-
tomycin, kanamycin, gentamicin, and 
vancomycin was tested by using the 
disk diffusion method according to the 
criteria of the French Society for Mi-
crobiology (www.sfm.asso.fr). Of 72 
nonduplicate GAS isolates collected, 
25 (17 from inpatients, 8 from outpa-
tients) were identiﬁ  ed as tetracycline 
resistant; they were further character-
ized as described (3).
The emm types of these 25 tetra-
cycline-resistant strains were deter-
mined by sequencing the variable 5′ 
end of the emm gene and comparing 
sequences with the Centers for Dis-
ease Control and Prevention data-
base (www.cdc.gov/ncidod/biotech/
strep/doc.htm). Twenty-three strains 
were  emm44 type, 1 was emm105, 
and 1 emm83. Pulsed-ﬁ  eld gel elec-
trophoresis (PFGE) patterns obtained 
after DNA digestion by SmaI restric-
tion enzyme were compared accord-
ing to Tenover criteria (4). The epi-
demic clone including 22 strains was 
characterized by an identical PFGE 
pattern 44-A1, whereas PFGE pat-
tern 44-A5 of the remaining emm44 
strain differed by 4 DNA bands (Fig-
ure). Epidemic strains also shared the 
same biotype 3 obtained on rapid ID 
32 Strep strips (bioMérieux, Marcy 
l’Etoile, France). T types were deter-
mined on trypsinated bacteria by slide 
agglutination with type-speciﬁ  c anti-
sera. Eleven strains were type T11, 4 
type T11/12, 1 type T11/3/13/B3264, 
and 6 non–T-typeable.
All epidemic emm44 strains were 
susceptible to all antibacterial agents 
tested except tetracycline. MICs of 
tetracycline, determined with Etest 
method (AB Biodisk, Solna, Sweden), 
were 24–48 mg/L. Screening of strains 
by PCR for tet(M), tet(O), tet(K), and 
tet(L) genes showed tetracycline re-
sistance was related to tet(M) gene. A 
multiplex PCR for detection of speA, 
speB, speC, smeZ, and ssa toxin genes 
showed that epidemic strain possessed 
only speB gene.
Investigation conducted by lo-
cal health authorities showed that the 
ﬁ  rst 5 patients with emm44 strain were 
drug users sharing a squat (illegally 
occupied housing). Although this 
place was shut down at the end of Feb-
ruary after an outbreak of scabies, ad-
ditional cases of infections caused by 
emm44 strain occurred. Medical care 
is difﬁ  cult to implement for homeless 
persons, thus, we limited our action 
to swabbing symptomatic persons to 
treat them and to limit spread of the 
epidemic strain. Following recom-
mendations from the Institute for Pub-
lic Health Surveillance, in mid-April 
nurses at the 2 main social centers for 
homeless persons obtained samples 
from 17 persons. Eleven persons were 
infected with GAS, of whom 8 had not 
been swabbed before. All but 1 isolate 
was emm44.
Among the 22 patients infected 
with epidemic 44-A1 clone, 4 had sev-
eral successive isolations of this strain. 
Most (19) infections were secondary 
infections of skin injuries; others were 
abscesses (4), septic arthritis (2), nec-
rotizing fasciitis (1), erysipelas (1), 
and hygroma (1). Five isolates were 
from sterile sites (1 surgical sample of 
necrotizing fasciitis, 1 blood culture, 
and 3 joint ﬂ  uids). Most infections had 
favorable outcomes, with the excep-
tion of a 79-year old man who died 
of erysipelas. Patient median age was 
37 years (range 20–79 years); all but 
1 were men. Eighty-six percent had 
risk factors such as alcohol abuse (17, 
77%), homelessness (16, 73%), drug 
use (11, 50%), hepatitis C infection (4, 
8%), and HIV infection (1, 4.5%). Two 
patients had no identiﬁ  ed risk factors. 
Complete characteristics of 50 patients 
infected with a strain of GAS different 
from 44-A1 clone were not available. 
However, this population did differ by 
its sex ratio (28 men:22 women) and 
by older median age (47.3 years).
We report clonal spread of an 
emm44 tetracycline-resistant GAS 
strain in marginal populations (drug 
users and homeless persons) in 
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Figure. Pulsed-ﬁ  eld gel electrophoresis (PFGE) patterns of SmaI-restricted chromosomal 
DNA of Streptococcus pyogenes emm44 strains. Lane 1, Bacteriophage Lambda ladder 
PFGE Marker (New England Biolabs Inc., Beverly, MA, USA); lanes 2–11, PFGE patterns 
44-A2, 44-A3, 44-A4, 44-A5, 44-A6, 44-A7, 44-A8, 44-A, 44-B, and 44-A1 of emm44 
unrelated control strains; lanes 12–26 and 28–34, 22 identical 44-A1 PFGE patterns 
shared by the tetracycline-resistant outbreak isolates; lane 27, PFGE pattern 44-A5 of the 
nonclonal emm44 strain isolated during the same outbreak, which differs by 4 bands from 
the pattern 44-A1. LETTERS
Rennes. This strain, characterized 
by PFGE pattern 44-A1, represented 
22/25 tetracycline resistant GAS iso-
lates and 30% of the 72 GAS isolates 
identiﬁ  ed at the hospital in Pontchail-
lou in 2009. Locally, emergence of 
the 44-A1 clone led to the dramatic 
increase of GAS tetracycline resis-
tance, from 17% in 2008 to 35% in 
2009.  emm44 GAS strains, which 
share identical 5′emm sequences with 
previously designated M/ emm61 
strains (5), have mainly been isolated 
in Asia from throat and skin speci-
mens (6,7). They were rarely reported 
as responsible for invasive infections 
in France or other parts of the world 
(5,8). Polyclonal and emm25 and 
emm83 monoclonal GAS outbreaks 
have been recently described among 
drug users in Switzerland, the United 
Kingdom, and Spain (9,10) without 
robust evidence of enhanced viru-
lence of the causative GAS strains. 
In the outbreak we report, skin infec-
tions might be a leading cause of bac-
terial transmission between people 
living in poor hygienic conditions 
and overcrowded spaces. 
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Surface Layer 
Protein A Variant of 
Clostridium difﬁ  cile 
PCR-Ribotype 027
To the Editor: Rates and severity 
of Clostridium difﬁ  cile infection (CDI) 
have recently increased worldwide 
and correlate with dissemination of 
hypervirulent epidemic strains desig-
nated PCR-ribotype 027. CDI caused 
by this PCR-ribotype is characterized 
by strong toxin A and B production, 
presence of binary toxin genes, and, 
usually, a high level of resistance to 
ﬂ  uoroquinolones (1).
The mechanisms by which C. dif-
ﬁ  cile colonizes the gut during infection 
are poorly understood. In addition to 
the toxins, surface protein components 
are undoubtedly involved. In particu-
lar, the surface layer (S-layer) medi-
ates adhesion to enteric cells (2), but 
other functions have been proposed 
for this S-layer structure: it may act 
as a molecular sieve, protect against 
parasitic attack, or be a mechanism 
to evade the host immune system (3). 
Furthermore, the C. difﬁ  cile S-layer is 
the predominant surface antigen and is 
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